restricted. Clones were maintained by weekly stimulation with irradiated spleen cells and antigen, as described (6) . Spleen cells were isolated from BALB/c (for CDC35, Dl .l,, DI .6) and (BALB/c X A/J) F, (CAFI) mice (for CDC25) .8-12-wk-old mice were purchased from The Jackson Laboratory, Bar Harbor, ME, and maintained in accordance with guidelines of the Committee on Animals of the Harvard Medical School and those prepared by the Committee on Care and Use of Laboratory Animals of the Institute of Laboratory Animal Resources, National Research Council (DHEW publication F'cou'/ cw-/ouuft,rwoou"/uuou~itb^od and treated with mbonoyciu C (Sigma Chemical Co.) (50 jug/u,! final concentration) 6v 45 min at 37"C.
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Materials and Metho ti-mouse 4pRGG, y(ab) 2 fragments of rabbit To assure that mitomycin C treatment had inhibited proliferation, T cells were cultured with 100 U of IL-2 in each experiment and shown to not incorporate [sH] thymidine . For measuring IL-4 and IL-2 secretion, supernatants (SN) were collected on day 1 of culture and assayed at 50% vol/vol for stimulation of HT-2 cells in the presence and absence of anti-IL-4 (1 :40 dilution) or anti-IL-2 (1 :20) antibodies, and previously described (2) . For assays of IFN-'y secretion, day 1 SN were assayed at 25% vol/vol for growth inhibition of 2 X 10' WEHI-279 cells, in the absence and presence of anti-IFN-.y antibody, as described (23) . For all assays, standard curves were generated using recombinant lymphokines present in test SN. Purification and Culture ofB Cells . Small resting B cells were purified from the spleens of unprimed BALE/c or CAF1 mice, according to methods described by Kreiger et al. (24) . Spleen cells were treated with anti-Thy-1 .2, anti-Lyt-1 .2, and anti-Lyt-2 for 45 min at 4°C, followed by a 30-min incubation at 37°C in low tox rabbit complement (Cedarlane Laboratories Ltd ., Hornby, Ontario). The remaining cells were washed and placed on a discontinuous Percoll gradient composed of 2.5 ml each of 50, 60, 65, and 72% Percoll (Pharmacia, Uppsala, Sweden) . Approximately 10' cells were placed on the centrifuged (2,000 g) at 4°C for 12 min. Cells recovered at the 65/7 considered to be small resting B cells, corresponding to a density of 1 .081-1 .089 g/m These cells did not respond to the anti-IgM mAb, Bet2 (1 :4 dilution of hybridoma supernatant), of IL-4 alone, but did proliferate when Bet2 and IL-4 were present in a coimulation assay (25) . For the experiments described under results, 10' B cells were cultured with antigen, mitomycin C-treated T cells, LPS, or other stimuli in 0.2 ml of RPMI 1640 supplemented with 2 MM L-glutarnine, penicillin, streptomycin, nonessential amino acids, sodium pyruvate, 10 mM Hepes, 5 X 10-5 M 2-ME and 10% heat-inactivated FCS in flat-bottomed microculture plates at 37°C in 5% CO2. In addition, all expercontrois: B cells alone, and B cells with IL-2 or Con A to measure residual T cell contamination . No lymphokine secretion or proliferation was detected in these groups (not shown) .
Assaysfor B Cell Activation. For all experiments with resting B cells, two parallel sets of cultures were established. The first was used to measure B cell proliferation and lymphokine secretion. Supernatants (50 Al) were harvested after 24 h in all experiments for lymphokine assays, as described above, to demonstrate that the mitomycin C-treated T cells had been activated. Cultures were pulsed for 6 h with I jCi [sH]thymidine per well on day 3, harvested in a PHD cell harvester, and incorporated radioactivi by scintillation counting. The second set of cultures was used to measure IgM, IgGI, an IgG2a and in the SN, by an ELISA. In brief, flexible microtiter plates were coated overnight at 4'C with polyvalent goat anti-mouse Ig (5 Ag/ml) (Southern Biotechnology Associates, Inc., Birmingham, AL), washed and blocked with 1% BSA (Sigma Chemical Co.) in PBS (pH 7 .2). Culture supernatants were added to microtiter wells for 4 h at room temperature and washed . The presence of IgM, IgGI, and IgG2a was detected after incubation with alkaline phosphatase-labeled affinity-purified goat anti-mouse antibodies specific for each isotype (Southern Biotechnology Associates, Inc.), the addition of substrate 0-nitrophenyl phosphate-disodium; (Sigma Chemical Co.), and measurement of the optical density at 405 nm. 4-day SN were used for IgM and IgGI measurement, at a 1 :4 dilution, and 7-d SN were used for IgG2a measurement at a 1 :2 dilution . Standard curves were obtained for each experiment with purified myeloma proteins of known isotypes (ICN, Lisle, IL), which were run in parallel . Results are expressed as the mean nanograms/milliliter of antibody present in SN of duplicate cultures. There was no crossreaction of the alkaline phosphatase-labeled affinity-purified goat antibodies with the propriate myeloma proteins in the 10,000 to 0.1 ng/ml range . Positive control culfor IgM, IgG, and IgG2a secretion were B cells incubated with LPS, LPS -1-Il.-4 (100 U/ml), and LPS -}-IFN--t (10 U/ml), respectively (17) .
Results
Presentation of RAMG by Small Resting B Cells to RGti-specific Thl and Th2 Clones . Initial studies were aimed at establishing the feasibility of our experi- mental system for analyzing cognate T-B interactions, by determining the ability of small resting B cells to present the model antigen, F(ab')2 RAMG, to RGGspecific T cells. As shown in Fig . 1 , both Thl (DIA and D1 .6) and Th2 (CDC25 and CDC35) cells secreted lymphokine when cultured with purified B cells and F(ab')2 RAMG at concentrations of 0.1-1 Ag/ml . Antibody blocking confirmed that the lymphokine measured in these assays was IL-2 or IL-4, respectively . Moreover, both purified B cells and irradiated splenocytes presented F(ab')2 RGG at 1O3-10'-fold higher concentrations than F(ab')2 RAMG, again confirming the efficiency of Ig-mediated antigen presentation (26, 27) . Finally, only the Thl clones secreted IFN-'Y in response to antigen presented by B cells, and the antigen dose-response was identical to that seen for IL-2 secretion (Fig. 2) . These experiments showed that both subsets of T cells gave equivalent responses to antigen presented by purified small resting B lymphocytes. We could, therefore, use this system for studying the activation of B cells as a consequence of cognate interactions with Thl and Th2 clones .
Induction of B Cell Proliferation and Differentiation by Thl and Th2 Clones . To first determine the optimal cell numbers for measuring helper function, we examined the ability of mitocycin C-treated T cell clones to activate B cells to proliferate in the presence of antigen. Increasing numbers (10i-105) of T cells were added to 10 5 B cells with 0-1 gg/ml of F(ab') z RAMG, and proliferation was assayed on day 3 . As few as 10 3 Th2 cells (CDC25 and CDC35) induced significant, antigen-dependent B cell proliferation, and 5 X 10 3 T cells gave near-maximal responses. In contrast, the Thl clones induced little or no B cell proliferation at any cell number (Fig . 3) , even though lymphokine secretion was readily detectable . Moreover, the mitomycin-treated T cells did not proliferate in response to Con A or IL-2, and no DNA synthesis was detectable if the B cells were also treated with mitomycin C (not shown) .
Based on these results, in subsequent experiments we used 5 X 10 ; T cells and 10 5 B cells for studying antigen-specific help . Parallel cultures were assayed for B cell proliferation and secretion of IgM, IgGI, and IgG2a. Only the Th2 clones, CDC25 and CDC35, induced both proliferation and secretion of IgM and IgGI (Fig . 4) . The Thl clones stimulated neither B cell growth nor antibody secretion. Moreover, neither subset of T cells was capable of eliciting an IgG2a response, although B cells cultured with LPS and 10 U/ml of IFN--Y secreted 182 and 310 ng/ml of IgG2a in two experiments. of different lymphokines to Th2-mediated B cell proliferation and antibody secretion were evaluated using neutralizing mAbs . As shown in Table I , anti-IL-4 significantly inhibited proliferation and IgGI production, especially in the presence of 0.1 Ag/ml of F(ab') 2 RAMG, when the levels of lymphokines secreted are lower than at higher antigen concentrations . This is consistent with the view that IL-4 is primarily involved in proliferation of and IgGI secretion by B cells (16) . It is noteworthy that proliferation is only partly inhibited by anti-IL-4, suggesting that other pathways may also be operative (e .g ., reference 28). Anti-IL-4 also significantly inhibited IgM secretion, especially at RAMG concentrations of 0 .1 /Ag/ml . Antibody to IL-5 had no effect on B cell proliferation, but inhibited both IgM and IgGI secretion. Even more striking was the result obtained using a combination of the two antibodies, which completely abrogated secretion of both IgM and IgGI . These experiments demonstrate different but Table 1 ) . The extent of inhibition was comparable to that observed with anti-IL-4 antibody. There was, however no IgG2a response under these conditions . The addition of 10 U/ml of IFN--f to LPS-stimulated B cells led to 272 ng/ml of IgG2a secretion in this experiment .
Inhibitory Effects of Thl Cells and the Role of IFN. Numerous studies have shown that IFN-y has an antiproliferative effect on activated B lymphocytes (23, 28, 29) . To determine if such inhibition was also observed in cognate T-B interactions, BALB/c B cells were cultured with F(ab')z RAMG and mixtures of RGG -l-I-Ad-specific Thl and Th2 clones . As shown in Fig. 5 , the Th2 clone CDC35 induced proliferation and Ig secretion . In contrast, the Thl clone Dl .l failed to activate B cells . When both clones were added together, D1 .1 markedly inhibited the two B cell responses that are most dependent on IL-4, i .e., proliferation and IgGI secretion, and this inhibition was reversed by anti-IFN-y antibody. These results raised the possibility that the apparent inability of Thl cells to help B lymphocytes may be due to a dominant inhibitory effect of IFN-y . To test this possibility, a saturating concentration of anti-IFN-y antibody was added to cultures of B cells, antigen, and Thl clones . As shown in Table II , no proliferation or antibody secretion was detected . It is also noteworthy that when the B cells were stimulated by LPS, the addition of antigen and Thl cells did lead to IgG2a secretion . This result is consistent with the view that IFN-y inhibits early events in B cell activation that are induced by IL-4, but mediates a switch to IgG2a under conditions where the inhibitory effect is not dominant (e .g., in LPS-stimulated cultures) .
Bystander Help by Thl and Th2 Cells. (Table III) . Controls showed that neither the A/J(I-Ak) nor the mitomycin C-treated BALB/c B cells cultured separately could be activated under these conditions .
Discussion
Despite a vast amount of work, the requirements for antigen-specific, helper T cell-dependent activation of B lymphocytes remain poorly defined. Thus, many cytokines, including IL-1, IL-2, IFN-'y, IL-4, and IL-5, have been shown to influence B cell growth and/or differentiation in vitro (9) (10) (11) (16) (17) (18) , but the critical question of which are obligatory for antibody responses to low (physiologic) concentrations of protein antigens is not yet resolved . The recent identification if la-restricted helper T cell subsets that differ in lymphokine secretion profiles, and the development of neutralizing antibodies specific for lymphokines, provide two approaches for addressing this question . In the studies described in this paper, we have used both approaches to analyze the activation of resting B lymphocytes by la-restricted T cells. In particular, we have compared the helper functions of a panel of T cell clones with the same antigenic specificity but belonging to the Thl and Th2 subsets. Several aspects of the experimental system used in these studies are noteworthy . First, we have used unselected small, resting B cells and anti-Ig as a model antigen, so that activation Table I . D1 .1 . cells secreted > 60 U/ml IL-2 in response to RAMG and untreated or mitomycin C-treated BALB/c B cells.
of the maximum possible number of cells can be assayed without the bias imposed by affinity purification and variations in the avidity of antigen-receptor interactions (13, 14) . Second, we have assayed the same or parallel cultures for stimulation of the helper T cell clones (by measuring IL-2 or IL-4 secretion) and for different aspects of the B cell response (proliferation and antibody production). Finally, we have measured the secretion of three different antibody isotypes, IgM, IgGI, and IgG2a, whose production may depend on different lymphokines (17) . The major conclusion from these studies is that Th2 clones (CDC25 and CDC35) induce both proliferation of and IgM and IgGI secretion by resting B cells. Th2 cells stimulate B lymphocytes that they interact with directly as well as bystander B cells. In contrast, Thl clones of the same specificity (D1 .1 . and D1 .6) fail to activate B cells in any of the assays used (Figs. 3 and 4 , Table III ) . In fact, IFN-y produced by Thl cells inhibits B cell activation, its major effect being on the IL-4-dependent responses, i.e ., proliferation and IgGI secretion (Fig. 5) . The failure of Thl cells to help resting B lymphocytes cannot, however, be attributed to a dominant inhibitory effect of IFN-y, since helper function cannot be restored to Thl cells by the addition of anti-IFN-y antibody (Table  II) . These results indicate that Thl cells do not produce the factors necessary for activating resting B lymphocytes, and that neither IL-2 nor IFN -'Y is obligatory for such responses. Such a conclusion contradicts a number of earlier studies showing that IL-2 and IFN-y are important helper factors for B cells (9) (10) (11) (12) . Many of these earlier studies used erythrocytes as antigens (9, 12) , and it is possible that this represents a unique situation that cannot be extrapolated to soluble proteins . Moreover, we and others have shown that Thl cells (and their secreted mediators) can help previously activated B cells (23) lated polyclonally in the presence of high concentrations of antigen (4), particularly if the inhibitory effect of IFN-y is neutralized. This suggests that different mechanisms may lead to stimulation of resting and activated B cells, and studies are currently under way to formally address this possibility.
The stimulation of resting B cells by Th2 clones is dependent on both IL-4 and IL-5 . Thus, antibody inhibition experiments indicate that IL-4 is the major lymphokine involved in IgGI secretion and plays a role in proliferation, although other mechanisms may also contribute to increased DNA synthesis (30) . On the other hand, IL-5 is not a growth factor for B cells under these conditions, but is necessary for maximal IgM production and may also contribute to the IgGI response ( Table I ). The observation that combinations of the two antibodies completely inhibit differentiation of resting B cells indicates that cognate help mediated by Th2 cells can be attributed to these two lymphokines.
Despite the potent helper activity of the Th2 clones, these cells are incapable of inducing IgG2a responses . Controls done in parallel using polyclonally (LPS) stimulated B cells confirmed the findings of Snapper and Paul (17) that IFN-'r is both necessary and sufficient for the switch to IgG2a . Thus, IFN-y has two opposing effects: it partially inhibits B cell proliferation and production of some antibody isotypes (most notably IgGl), but is required for the secretion of IgG2a. This raises the obvious question of how IgG2a responses are induced in physiologic situations, especially when both subsets are likely to be activated . It is possible that the production of this isotype may require a balance between IL-4 and IFN-y, such that high concentrations of IL-4 may override the inhibitory influence of IFN-y and initiate responses that culminate in B cell proliferation and secretion of all Ig isotypes when both Thl and Th2 cells are present and activated . Alternatively, IgG2a secretion may depend on sequential stimulation of B cells, first with a Th2 helper cell that will induce clonal proliferation and IgM and IgGI, and subsequently with a Thl cell that will selectively mediate the switch to IgG2a. We are currently testing these possibilities using the panel of clones and recombinant lymphokines described above .
Finally, we have also shown that both Thl and Th2 clones respond maximally to antigen presented by highly purified B cells, as measured by lymphokine secretion (Fig. 1) . Moreover, B cells present ligands that bind to their Ig receptors at much lower concentrations than antigens taken up by receptor-independent pathways or antigens presented by irradiated splenocytes (26) , and this is true for both subsets of T cells. Thus, at least in the short-term stimulation assays used in these experiments, Thl and Th2 subsets do not respond preferentially to antigen presented by different presenting cells (B cells or irradiated whole splenocytes) . One might predict that the most efficient APC for Thl cells are macrophages, since IFN-y induces la expression on macrophages, and for Th2 clones are B cells, since IL-4 enhances B cell la expression . This may occur under limiting conditions, but is clearly not the case at the cell numbers and antigen concentrations that we have used. It is also possible that different T cell subsets vary in proliferative responses to antigen presented by different accessory cells, and this reflects the requirement for costimulators such as IL-1 . Thus, it is known that Th2 cells are IL-1 sensitive whereas Thl cells are not (6) . To what extent the activation, proliferation, and function of Thl and Th2 cells are dependent on selective pressures imposed by different APCs is a question that remains to be resolved.
Summary
To compare the helper function of murine T cell clones that secrete IL-2 and IFN-y (Thl cells) or IL-4 and IL-5 (Th2), purified resting B cells were stimulated with F(ab')2 rabbit anti-mouse Ig (RAMG) and rabbit Ig-specific, class II MHC-restricted cloned T cells belonging to the two subsets . Both Th2 clones examined induced strong proliferative responses of B cells in the presence of RAMG, as well as the secretion of IgM and IgGI antibodies. In contrast, the Thl clones tested failed to stimulate B cell growth or antibody secretion . Th2-mediated B cell activation was dependent on IL-4 and IL-5, and was also inhibited by IFN-y or IFN-y produced by Thl cells present in the same cultures . However, the failure of Thl cells to help resting B cells could not be reversed with neutralizing anti-IFN-y antibody. In addition to this inhibitory effect, IFNy was required for the secretion of IgG2a antibody, particularly when B cells were stimulated with polyclonal activators such as LPS. Finally, both sets of T cell clones secreted lymphokines when stimulated with purified B cells and RAMG. These experiments demonstrate that T cells that differ in lymphokine production also differ in their ability to help B cells as a result of cognate interactions at low concentrations of antigens. Moreover, IL-4, IL-5, and IFN-y serve different roles in the T cell-dependent proliferative and differentiative responses of resting B lymphocytes .
